Antimicrobial susceptibilities of Clostridium difficile isolated in Japan

Hiroyuki Kunishima1, Junichi Chiba, Michiko Saito

  • 1Department of Infection Control and Laboratory Diagnostics, Internal Medicine, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, Japan. h2kuni@med.tohoku.ac.jp

Insights

All Japanese Clostridium difficile isolates were susceptible to metronidazole (MNZ) and vancomycin (VCM). Continuous monitoring is crucial as resistant strains may emerge, impacting antimicrobial-associated diarrhea treatment.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Antimicrobial Resistance

Background:

  • Clostridium difficile causes antimicrobial-associated diarrhea and nosocomial infections.
  • Metronidazole (MNZ) and vancomycin (VCM) are standard treatments.
  • Emergence of MNZ-resistant strains necessitates ongoing surveillance.

Purpose of the Study:

  • To determine the susceptibility of clinical Clostridium difficile isolates in Japan to various antimicrobial agents.
  • To assess the minimum inhibitory concentrations (MICs) of 15 drugs against C. difficile.

Main Methods:

  • Broth microdilution method was employed.
  • 157 clinical isolates of C. difficile from Japan were tested.
  • MICs for 15 different drugs were determined.

Main Results:

  • All 157 C. difficile isolates were susceptible to metronidazole (MNZ).
  • All isolates were also susceptible to vancomycin (VCM) and teicoplanin.
  • MIC ranges and MIC50/MIC90 values for MNZ, VCM, and teicoplanin were established.

Conclusions:

  • Current Japanese C. difficile isolates remain susceptible to MNZ and VCM.
  • Continuous monitoring of antimicrobial susceptibility is essential to detect potential resistance.
  • Proactive surveillance will guide future treatment strategies for C. difficile infections.

Related Concept Videos

Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...